Prolylcarboxypeptidase: A cardioprotective enzyme

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 3, 2009, Pages 477-481

  Mallela, J ^a   Yang, J ^a   Shariat Madar, Z ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Angiotensin; Prekallikrein; Prolylcarboxypeptidase

Indexed keywords

ALPHA INTERMEDIN; ANGIOTENSIN II; ANGIOTENSIN III; BRADYKININ; DEXAMETHASONE; GLUCOCORTICOID; MU OPIATE RECEPTOR AGONIST; PREKALLIKREIN; PROLINE CARBOXYPEPTIDASE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD VESSEL TONE; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; HEART PROTECTION; HUMAN; NUCLEOTIDE SEQUENCE; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; TONSILLITIS; UPREGULATION; VASCULAR ENDOTHELIUM;

ARTHRITIS, RHEUMATOID; BLOOD COAGULATION FACTORS; CAPILLARY PERMEABILITY; CARBOXYPEPTIDASES; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; NEUROPEPTIDES; PRE-ECLAMPSIA; PREGNANCY; TONSILLITIS;

EID: 58149293537     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.02.022     Document Type: Short Survey

References (20)

1. Al-Aloul B., Li J.M., Benditt D., and Tholakanahalli V. Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism (Conn's syndrome). Pacing Clin. Electrophysiol. 29 (2006) 1303-1305
2. Catania A., Gatti S., Colombo G., and Lipton J.M. Alpha-melanocyte stimulating hormone in modulation of inflammatory reactions. Pediatr. Endocrinol. Rev. 1 (2003) 101-108
3. Felix D., Khosla M.C., Barnes K.L., Imboden H., Montani B., and Ferrario C.M. Neurophysiological responses to angiotensin-(1-7). Hypertension 17 (1991) 1111-1114
4. Gammelgaard I., Wamberg S., and Bie P. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the rennin-angiotensin-aldosterone-system. Acta Physiol. (Oxf.) 188 (2006) 129-138
5. Hooley E., McEwan P.A., and Emsley J. Molecular modelling of the Prekallikrein structure provide insights into HK binding and zymogen activation. J. Thromb. Haemost. (2007)
6. Huentelman M.J., Grobe J.L., Vazquez J., Stewart J.M., Mecca A.P., Katovich M.J., et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp. Physiol. 90 (2005) 783-790
7. Jackman H.L., Tan F., Schraufnagel D., Dragovic T., Dezso B., Becker R.P., et al. Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 13 (1995) 196-204
8. Kumamoto K., Stewart T.A., Johnson A.R., and Erdos E.G. Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells. J. Clin. Invest. 67 (1981) 210-215
9. Odya C.E., Marinkovic D.V., Hammon K.J., Stewart T.A., and Erdos E.G. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J. Biol. Chem. 253 (1978) 5927-5931
10. Palmeri D., Zuo F.R., Rosen S.D., and Hemmerich S. Differential gene expression profile of human tonsil high endothelial cells: implications for lymphocyte trafficking. J. Leukoc. Biol. 75 (2004) 910-927
11. Pawluczyk I.Z., Patel S.R., and Harris K.P. Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells. Cell. Physiol. Biochem. 18 (2006) 327-336
12. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 103 (2004) 4554-4561
13. Silva D.M., Vianna H.R., Cortes S.F., Campagnole-Santos M.J., Santos R.A., and Lemos V.S. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28 (2007) 702-707
14. Skidgel R.A., and Erdos E.G. Cellular carboxypeptidases. Immunol. Rev. 161 (1998) 129-141
15. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16899-16903
16. Tamaoki J., Sugimoto F., Tagaya E., Isono K., Chiyotani A., and Konno K. Angiotensin II 1 receptor-mediated contraction of pulmonary artery and its modulation by prolylcarboxypeptidase. J. Appl. Physiol. 76 (1994) 1439-1444
17. Tan F., Morris P.W., Skidgel R.A., and Erdos E.G. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J. Biol. Chem. 268 (1993) 16631-16638
18. Wang L., Feng Y., Zhang Y., Zhou H., Jiang S., Niu T., et al. Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia. Am. J. Obstet. Gynecol. 195 (2006) 162-171
19. Ward G.R., Franklin S.O., Gerald T.M., Dempsey K.T., Clodfelter Jr. D.E., Krissinger D.J., et al. Glucocorticoids plus opioids up-regulate genes that influence neuronal function. Cell. Mol. Neurobiol. 27 (2007) 651-660
20. Watson Jr. B., Nowak N.J., Myracle A.D., Shows T.B., and Warnock D.G. The human angiotensinase C gene (HUMPCP) maps to 11q14 within 700 kb of D11S901: A candidate gene for essential hypertension. Genomics 44 (1997) 365-367